REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 145 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $36,000 | -16.3% | 2,597 | +17.4% | 0.00% | – |
| Q1 2022 | $43,000 | 0.0% | 2,213 | -16.9% | 0.00% | – |
| Q4 2021 | $43,000 | -17.3% | 2,662 | +42.0% | 0.00% | – |
| Q3 2021 | $52,000 | -7.1% | 1,874 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $56,000 | -15.2% | 1,874 | -21.1% | 0.00% | 0.0% |
| Q1 2021 | $66,000 | +34.7% | 2,374 | +36.3% | 0.00% | 0.0% |
| Q4 2020 | $49,000 | +11.4% | 1,742 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $44,000 | 0.0% | 1,742 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $44,000 | +1366.7% | 1,742 | +771.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
| Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
| ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
| Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
| Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
| Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
| EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
| PointState Capital LP | 438,200 | $11,568,000 | 0.13% |